Evidence map›Paper›PMID 38279008›Full record

ArticleBone marrow transplantation2024

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan and 11 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 2 countries.

Dawn MazeThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. dawn.maze@uhn.ca.ORCID http://orcid.org/0000-0002-4598-9380
Murat O ArcasoyDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Ryan HenrieDivision of Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Sonia CerquozziTom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
Rammurti KambleCenter for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA.
Samer Al-HadidiMyeloma Section, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Abdulraheem YacoubDivision of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
Anurag K SinghDivision of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0003-1114-9508
Mahmoud ElsawyDivision of Hematology, Dalhousie University, Halifax, NS, Canada.ORCID http://orcid.org/0000-0001-9872-2471
Shireen SirhanJewish General Hospital, McGill University, Montreal, QC, Canada.
Elliot SmithThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Curtis MarcouxDivision of Hematology, Dalhousie University, Halifax, NS, Canada.
Auro ViswabandyaThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-9690-4669
Andrew DalyTom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
Hassan SibaiThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Caroline McNamaraThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Yuliang ShiDepartment of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Wei XuDepartment of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Katherine LajkoszDepartment of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Lynda FoltzDivision of Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Vikas GuptaThe Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-1419-8607
University of Toronto · CAUniversity Health Network · CAAlberta Health Services · CADalhousie University · CAUniversity of British Columbia · CAUniversity of Kansas Medical Center · USBaylor College of Medicine · USDuke University · USJewish General Hospital · CAWinthrop Rockefeller Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38279008
PMCPMC10849954
OpenAlexW4391260620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.